{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=43500","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=completion_date&start=42900","results":[{"registry_id":"NCT05301816","publication_url":"https://clinicaltrials.gov/study/NCT05301816","title":"A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.","has_exemption":false,"start_date":"2022-07-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Nevro Corp","sponsor_slug":"nevro-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05296798","publication_url":"https://clinicaltrials.gov/study/NCT05296798","title":"A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant in Combination With Phesgo Versus Phesgo After Induction Therapy With Phesgo + Taxane in Patients With Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally-Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2022-07-18","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384535","publication_url":"https://clinicaltrials.gov/study/NCT05384535","title":"Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort","has_exemption":false,"start_date":"2022-08-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05570253","publication_url":"https://clinicaltrials.gov/study/NCT05570253","title":"\"A Phase 2, Double Blinded, Randomized Controlled Trial of Evexomostat (SDX-7320) or Placebo in Combination With Eribulin for Patients With Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study","has_exemption":false,"start_date":"2022-10-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514054","publication_url":"https://clinicaltrials.gov/study/NCT05514054","title":"EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317806","publication_url":"https://clinicaltrials.gov/study/NCT05317806","title":"Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population","has_exemption":false,"start_date":"2022-10-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Indiana Hemophilia &Thrombosis Center, Inc.","sponsor_slug":"indiana-hemophilia-thrombosis-center-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556512","publication_url":"https://clinicaltrials.gov/study/NCT05556512","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity","has_exemption":false,"start_date":"2022-10-11","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03887481","publication_url":"https://clinicaltrials.gov/study/NCT03887481","title":"Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)","has_exemption":false,"start_date":"2022-10-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05256225","publication_url":"https://clinicaltrials.gov/study/NCT05256225","title":"A Phase III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma","has_exemption":false,"start_date":"2022-11-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05492799","publication_url":"https://clinicaltrials.gov/study/NCT05492799","title":"Open-Label Multicenter Extension Study to Further Evaluate Safety, Tolerability and Efficacy of Intracerebroventricular AX 250 Treatment in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Patients","has_exemption":false,"start_date":"2022-12-02","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Allievex Corporation","sponsor_slug":"allievex-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650229","publication_url":"https://clinicaltrials.gov/study/NCT05650229","title":"An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Adaptive Study of the Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Abliva AB","sponsor_slug":"abliva-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05640947","publication_url":"https://clinicaltrials.gov/study/NCT05640947","title":"Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass: a Proof of Concent Study","has_exemption":false,"start_date":"2023-01-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Ghent","sponsor_slug":"university-hospital-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02616302","publication_url":"https://clinicaltrials.gov/study/NCT02616302","title":"A Phase 2, Double-Blind, 12-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 2 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease","has_exemption":false,"start_date":"2023-02-20","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05644496","publication_url":"https://clinicaltrials.gov/study/NCT05644496","title":"A Randomized Controlled Trial of ZYNRELEF Versus Standard of Care for Pain Management Following Unilateral Total Knee Arthroplasty","has_exemption":false,"start_date":"2023-03-09","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Baptist Health South Florida","sponsor_slug":"baptist-health-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05807399","publication_url":"https://clinicaltrials.gov/study/NCT05807399","title":"A Multiple-arm, Multiple-stage (MAMS), Phase 2B/C, Open-label, Randomized, Controlled Platform Trial to Evaluate Experimental Arms Including Optimised Use of Existing and Introduction of Novel Anti-tuberculosis Drugs, in Adults With Newly Diagnosed, Drug-sensitive, Smear-positive Pulmonary Tuberculosis","has_exemption":false,"start_date":"2023-04-14","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Michael Hoelscher","sponsor_slug":"michael-hoelscher","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05707377","publication_url":"https://clinicaltrials.gov/study/NCT05707377","title":"A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy","has_exemption":false,"start_date":"2023-04-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05712057","publication_url":"https://clinicaltrials.gov/study/NCT05712057","title":"Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis","has_exemption":false,"start_date":"2023-05-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02615184","publication_url":"https://clinicaltrials.gov/study/NCT02615184","title":"A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE","has_exemption":false,"start_date":"2023-05-23","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907343","publication_url":"https://clinicaltrials.gov/study/NCT05907343","title":"Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564598","publication_url":"https://clinicaltrials.gov/study/NCT05564598","title":"A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05721027","publication_url":"https://clinicaltrials.gov/study/NCT05721027","title":"Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.","has_exemption":false,"start_date":"2023-07-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901675","publication_url":"https://clinicaltrials.gov/study/NCT05901675","title":"Enhancing Mobility and Psychosocial Function in Obese Veterans Following Stroke Via Weight Loss and ExeRcise (EMPOWER)","has_exemption":false,"start_date":"2023-07-07","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514899","publication_url":"https://clinicaltrials.gov/study/NCT05514899","title":"Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV","has_exemption":false,"start_date":"2023-09-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05693909","publication_url":"https://clinicaltrials.gov/study/NCT05693909","title":"An Open-label, Dose-escalation, Dose-finding, and Proof-of-concept Trial of SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2023-09-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Pharmacosmos A/S","sponsor_slug":"pharmacosmos-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066346","publication_url":"https://clinicaltrials.gov/study/NCT06066346","title":"Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2023-09-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06099769","publication_url":"https://clinicaltrials.gov/study/NCT06099769","title":"A RANDOMIZED, PHASE II STUDY OF ENZALUTAMIDE, ENZALUTAMIDE WITH MIFEPRISTONE, and TREATMENT OF PHYSICIAN'S CHOICE IN PATIENTS WITH AR+ METASTATIC TRIPLE-NEGATIVE OR ER-LOW BREAST CANCER","has_exemption":false,"start_date":"2023-10-18","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05769153","publication_url":"https://clinicaltrials.gov/study/NCT05769153","title":"A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05836584","publication_url":"https://clinicaltrials.gov/study/NCT05836584","title":"A Randomized Phase II Study of Perioperative Atezolizumab +/- Chemotherapy in Resectable MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06244771","publication_url":"https://clinicaltrials.gov/study/NCT06244771","title":"An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 in Participants With KRAS G12C Mutated Locally Advanced Unresectable or Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-02-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Frontier Medicines Corporation","sponsor_slug":"frontier-medicines-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06149481","publication_url":"https://clinicaltrials.gov/study/NCT06149481","title":"Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)","has_exemption":false,"start_date":"2024-03-26","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214065","publication_url":"https://clinicaltrials.gov/study/NCT06214065","title":"Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder Using Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2024-04-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439277","publication_url":"https://clinicaltrials.gov/study/NCT06439277","title":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06203600","publication_url":"https://clinicaltrials.gov/study/NCT06203600","title":"Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS &gt;/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)","has_exemption":false,"start_date":"2024-06-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470763","publication_url":"https://clinicaltrials.gov/study/NCT06470763","title":"A First-in-human, Open-label, Multicenter Phase I/II Study to Evaluate the Safety and Anti-tumor Activity of ANV600 as Single Agent and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)","has_exemption":false,"start_date":"2024-07-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Anaveon AG","sponsor_slug":"anaveon-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569368","publication_url":"https://clinicaltrials.gov/study/NCT06569368","title":"A Phase II Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy","has_exemption":false,"start_date":"2024-07-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736860","publication_url":"https://clinicaltrials.gov/study/NCT06736860","title":"Early and Precise Application and Evaluation of Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Nanfang Hospital, Southern Medical University","sponsor_slug":"nanfang-hospital-southern-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523556","publication_url":"https://clinicaltrials.gov/study/NCT06523556","title":"Phase 1b/2 Study of Axatilimab (SNDX-6352) + Azacitidine (AZA) in Advanced Phase MPN, MPN/MDS Overlap or High-Risk CMML","has_exemption":false,"start_date":"2024-08-02","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Uma Borate","sponsor_slug":"uma-borate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06268665","publication_url":"https://clinicaltrials.gov/study/NCT06268665","title":"A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy","has_exemption":false,"start_date":"2024-08-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06179888","publication_url":"https://clinicaltrials.gov/study/NCT06179888","title":"Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients","has_exemption":false,"start_date":"2024-08-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588413","publication_url":"https://clinicaltrials.gov/study/NCT06588413","title":"Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 mg Versus 5 mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: The FONDO-LOW Study","has_exemption":false,"start_date":"2024-09-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Augusta University","sponsor_slug":"augusta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06681922","publication_url":"https://clinicaltrials.gov/study/NCT06681922","title":"A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06529731","publication_url":"https://clinicaltrials.gov/study/NCT06529731","title":"A Phase 2 Trial of Interferon-γ (IFN-γ) in Combination With Donor Leukocyte Infusion (DLI) to Treat Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Sawa Ito, MD","sponsor_slug":"sawa-ito-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06458439","publication_url":"https://clinicaltrials.gov/study/NCT06458439","title":"Phase IIa Trial to Evaluate Epcoritamab Administered Before and After CAR-T Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphomas","has_exemption":false,"start_date":"2024-09-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06643312","publication_url":"https://clinicaltrials.gov/study/NCT06643312","title":"Tethered Pelvic Assist Device for Recovery of Standing After Severe SCI","has_exemption":false,"start_date":"2024-10-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06651567","publication_url":"https://clinicaltrials.gov/study/NCT06651567","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study of the Efficacy, Safety, and Tolerability of ITI-1284 in Patients With Agitation Associated With Alzheimer's Dementia","has_exemption":false,"start_date":"2024-10-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100172","publication_url":"https://clinicaltrials.gov/study/NCT06100172","title":"Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery","has_exemption":false,"start_date":"2024-10-29","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06483009","publication_url":"https://clinicaltrials.gov/study/NCT06483009","title":"Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai Chest Hospital","sponsor_slug":"shanghai-chest-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06511882","publication_url":"https://clinicaltrials.gov/study/NCT06511882","title":"Discontinuation of Hypomethylating Agent and Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Who Have Achieved Negative Measurable Residual Disease (MRD)","has_exemption":false,"start_date":"2024-11-07","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06690775","publication_url":"https://clinicaltrials.gov/study/NCT06690775","title":"Catalina-2: A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6","has_exemption":false,"start_date":"2024-11-20","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"TORL Biotherapeutics, LLC","sponsor_slug":"torl-biotherapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06634069","publication_url":"https://clinicaltrials.gov/study/NCT06634069","title":"A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients","has_exemption":false,"start_date":"2024-11-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital Pilsen","sponsor_slug":"university-hospital-pilsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609889","publication_url":"https://clinicaltrials.gov/study/NCT06609889","title":"A Phase 1/2 Open Label Study to Evaluate the Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease","has_exemption":false,"start_date":"2024-12-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Berge Minassian","sponsor_slug":"berge-minassian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568783","publication_url":"https://clinicaltrials.gov/study/NCT06568783","title":"Evaluation of Patients With Refractory Dermatomyositis Using [18F]- Fibroblast Activation Protein Inhibitor-74 (FAPI-74) PET/MRI Imaging","has_exemption":false,"start_date":"2024-12-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Farshad Moradi","sponsor_slug":"farshad-moradi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06192615","publication_url":"https://clinicaltrials.gov/study/NCT06192615","title":"Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)","has_exemption":false,"start_date":"2025-01-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782555","publication_url":"https://clinicaltrials.gov/study/NCT06782555","title":"A Phase 1/2 Immunotherapy Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab in Patients with Advanced Solid Malignancies","has_exemption":false,"start_date":"2025-01-08","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"ImmunoGenesis","sponsor_slug":"immunogenesis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06555003","publication_url":"https://clinicaltrials.gov/study/NCT06555003","title":"Comparative Analysis of the Efficacy of Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Combination With Systemic Chemotherapy Versus Chemotherapy Alone in Unresectable Colorectal Cancer Liver Metastases: a Randomized Clinical Trial","has_exemption":false,"start_date":"2025-01-20","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Tehran University of Medical Sciences","sponsor_slug":"tehran-university-of-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435156","publication_url":"https://clinicaltrials.gov/study/NCT06435156","title":"A Phase 2 Double-blind Randomised Controlled Trial Studying the Effect of Sotagliflozin Versus Placebo in Individuals With Heart Failure and Type 1 Diabetes.","has_exemption":false,"start_date":"2025-01-28","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Dundee","sponsor_slug":"university-of-dundee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630845","publication_url":"https://clinicaltrials.gov/study/NCT06630845","title":"Comparison of Whole Body DWI to FDG PET Using PET/MRI","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06617923","publication_url":"https://clinicaltrials.gov/study/NCT06617923","title":"A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561152","publication_url":"https://clinicaltrials.gov/study/NCT06561152","title":"Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123-Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603662","publication_url":"https://clinicaltrials.gov/study/NCT06603662","title":"Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department","has_exemption":false,"start_date":"2025-02-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"WellSpan Health","sponsor_slug":"wellspan-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610825","publication_url":"https://clinicaltrials.gov/study/NCT06610825","title":"A Phase II Clinical Trial to Evaluate the Efficacy and Safety of Fam-Trastuzumab Deruxtecan-Nxki (T-DXd) as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Washington D.C. Veterans Affairs Medical Center","sponsor_slug":"washington-dc-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06601296","publication_url":"https://clinicaltrials.gov/study/NCT06601296","title":"STING Agonist and Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer.","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07207395","publication_url":"https://clinicaltrials.gov/study/NCT07207395","title":"A Study of Open-label Orally Administered JBI-802 Alone or in Combination With Pembrolizumab in Patients With Advanced NSCLC Tumors Harboring an STK11 Mutation","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"The Christ Hospital","sponsor_slug":"the-christ-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06963034","publication_url":"https://clinicaltrials.gov/study/NCT06963034","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization","has_exemption":false,"start_date":"2025-05-08","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665997","publication_url":"https://clinicaltrials.gov/study/NCT06665997","title":"Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935591","publication_url":"https://clinicaltrials.gov/study/NCT06935591","title":"Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Vektor Medical","sponsor_slug":"vektor-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06904235","publication_url":"https://clinicaltrials.gov/study/NCT06904235","title":"A Multicentre, Multinational, Pharmacokinetic, Safety, and Efficacy Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC). A 2-part Study With Phase 2, Open-label, Randomised, Single-dose IV NEPA vs Fosaprepitant/Ondansetron in Single-day HEC and Repeated-dose IV NEPA in Multi-day HEC (Part I, Single Cycle) and With Phase 3, Double-blind, Randomised, Repeated-dose IV NEPA vs Fosaprepitant/Ondansetron in Multi-day HEC (Part II, Repeated Cycles)","has_exemption":false,"start_date":"2025-07-07","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Helsinn Healthcare SA","sponsor_slug":"helsinn-healthcare-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06692686","publication_url":"https://clinicaltrials.gov/study/NCT06692686","title":"The Development of Patient-Centered Clinical AFO Prescription Guidelines to Optimize Post-Stroke Function and Quality of Life","has_exemption":false,"start_date":"2025-07-08","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06923488","publication_url":"https://clinicaltrials.gov/study/NCT06923488","title":"Phase I/II Study of Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory (R/R) Myelodysplastic Syndromes (MDS)","has_exemption":false,"start_date":"2025-07-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018713","publication_url":"https://clinicaltrials.gov/study/NCT07018713","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Chronic Migraine","has_exemption":false,"start_date":"2025-08-21","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Merz Therapeutics GmbH","sponsor_slug":"merz-therapeutics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096843","publication_url":"https://clinicaltrials.gov/study/NCT07096843","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)","has_exemption":false,"start_date":"2025-08-25","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Climb Bio, Inc.","sponsor_slug":"climb-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06565390","publication_url":"https://clinicaltrials.gov/study/NCT06565390","title":"Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial","has_exemption":false,"start_date":"2025-09-11","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224451","publication_url":"https://clinicaltrials.gov/study/NCT07224451","title":"Liquid Biopsy Following Blood-Brain Barrier Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Sheba Medical Center","sponsor_slug":"sheba-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220967","publication_url":"https://clinicaltrials.gov/study/NCT07220967","title":"A Randomized Controlled Trial to Determine the Efficacy of Local Antibiotic Delivery in the Prevention of Breast Tissue Expander-Associated Infections","has_exemption":false,"start_date":"2025-10-21","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226297","publication_url":"https://clinicaltrials.gov/study/NCT07226297","title":"An Open-label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Charcot-Marie-Tooth Type 2D Due to GARS1 Genetic Mutation","has_exemption":false,"start_date":"2025-10-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06675435","publication_url":"https://clinicaltrials.gov/study/NCT06675435","title":"The Effect of Inhaled Nitric Oxide on Intrapulmonary Shunt in Acutely Hypoxemic Patients With Severe Obesity","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990945","publication_url":"https://clinicaltrials.gov/study/NCT06990945","title":"Clinical Performance And Radiographic Assessment Of Mesoporous Bioactive Glass Adhesive Vs. Universal Adhesive In Class II Carious Lesions","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197788","publication_url":"https://clinicaltrials.gov/study/NCT07197788","title":"Endogenex Access Study","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Endogenex, Inc.","sponsor_slug":"endogenex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07202273","publication_url":"https://clinicaltrials.gov/study/NCT07202273","title":"A Feasibility Study of Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases (SIM-FREE RT)","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220876","publication_url":"https://clinicaltrials.gov/study/NCT07220876","title":"A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Avisi Technologies Inc.","sponsor_slug":"avisi-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281079","publication_url":"https://clinicaltrials.gov/study/NCT07281079","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Orally Administered NNZ-2591 Compared With Placebo in Pediatric Participants With Phelan-McDermid Syndrome","has_exemption":false,"start_date":"2025-11-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Neuren Pharmaceuticals Limited","sponsor_slug":"neuren-pharmaceuticals-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092566","publication_url":"https://clinicaltrials.gov/study/NCT07092566","title":"Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial","has_exemption":false,"start_date":"2025-11-14","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222072","publication_url":"https://clinicaltrials.gov/study/NCT07222072","title":"Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study","has_exemption":false,"start_date":"2025-11-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209462","publication_url":"https://clinicaltrials.gov/study/NCT07209462","title":"Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants With Fragile X Syndrome","has_exemption":false,"start_date":"2025-11-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07199764","publication_url":"https://clinicaltrials.gov/study/NCT07199764","title":"IGNITE: A Phase 2 Study of Maintenance Combinatorial Myeloid Immunotherapy in Patients With Unresectable Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2025-11-25","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07249372","publication_url":"https://clinicaltrials.gov/study/NCT07249372","title":"A Phase 2 Study of DRP-104, a Glutamine Antagonist, in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07114718","publication_url":"https://clinicaltrials.gov/study/NCT07114718","title":"Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Starlight Cardiovascular Inc","sponsor_slug":"starlight-cardiovascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07052929","publication_url":"https://clinicaltrials.gov/study/NCT07052929","title":"A Phase 1/2, Multicenter, Open-label, Dose Escalation and Expansion Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of ASP2957 in Male Participants With Invasive Ventilator-dependent X-linked Myotubular Myopathy","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Gene Therapies","sponsor_slug":"astellas-gene-therapies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861088","publication_url":"https://clinicaltrials.gov/study/NCT06861088","title":"A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer (CATIQ P3)","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Quercis Pharma AG","sponsor_slug":"quercis-pharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07167693","publication_url":"https://clinicaltrials.gov/study/NCT07167693","title":"Phase 1 Randomized Clinical Trial of Arginine Hydrochloride Administration to Reduce Duration of Diabetic Ketoacidosis in Patients With Type 2 Diabetes","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"David K Carroll","sponsor_slug":"david-k-carroll","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449923","publication_url":"https://clinicaltrials.gov/study/NCT07449923","title":"A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2026-02-09","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"EyePoint Pharmaceuticals, Inc.","sponsor_slug":"eyepoint-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07449936","publication_url":"https://clinicaltrials.gov/study/NCT07449936","title":"A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"EyePoint Pharmaceuticals, Inc.","sponsor_slug":"eyepoint-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146230","publication_url":"https://clinicaltrials.gov/study/NCT07146230","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201402","publication_url":"https://clinicaltrials.gov/study/NCT07201402","title":"Prospective Long-term Study of Etonogestrel Contraceptive Implant Insertion at an Alternative Scapular Site","has_exemption":false,"start_date":"2026-03-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07500090","publication_url":"https://clinicaltrials.gov/study/NCT07500090","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) Followed by an Open-label Extension","has_exemption":false,"start_date":"2026-03-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Harmony Biosciences Management, Inc.","sponsor_slug":"harmony-biosciences-management-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07474792","publication_url":"https://clinicaltrials.gov/study/NCT07474792","title":"A Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Dose-Range Finding Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Participants With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2026-03-19","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Oruka Therapeutics, Inc.","sponsor_slug":"oruka-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07446998","publication_url":"https://clinicaltrials.gov/study/NCT07446998","title":"PLATEAU: Phase 2b Proof-of-Concept Study to Evaluate the Effect on Total Body Weight, Physical Function and Safety of Enobosarm in Patients Treated With Semaglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, for Weight Reduction","has_exemption":false,"start_date":"2026-03-26","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Veru Inc.","sponsor_slug":"veru-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04266275","publication_url":"https://clinicaltrials.gov/study/NCT04266275","title":"An Investigation in the Use of Curcumin Topical Herbal Agent for the Treatment of Cervical Intraepithelial Neoplasia","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Lisa Flowers","sponsor_slug":"lisa-flowers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07291180","publication_url":"https://clinicaltrials.gov/study/NCT07291180","title":"A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091448","publication_url":"https://clinicaltrials.gov/study/NCT07091448","title":"Prospective, Assessment of Alveolar Ridge Preservation Using Biotivity™ Amnion Chorion Membranein Atraumatic Extraction Socket","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216404","publication_url":"https://clinicaltrials.gov/study/NCT07216404","title":"Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)","has_exemption":false,"start_date":"2026-04-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Alan Davis","sponsor_slug":"alan-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792500","publication_url":"https://clinicaltrials.gov/study/NCT06792500","title":"Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218952","publication_url":"https://clinicaltrials.gov/study/NCT07218952","title":"Ultra-low Dose, DaT-SPECT-guided Radiation Therapy for the Treatment of Parkinson's Disease","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07265674","publication_url":"https://clinicaltrials.gov/study/NCT07265674","title":"A Phase 3, Multicenter, Randomized, Open-label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients With Previously Treated Advanced Biliary Tract Cancer","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"J-Pharma Co., Ltd.","sponsor_slug":"j-pharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07270380","publication_url":"https://clinicaltrials.gov/study/NCT07270380","title":"A Multi-center, Single-arm, Historically Controlled Pivotal Trial, to Assess the Safety and Effectiveness of Genex G as Part of the Surgical Treatment of Osteomyelitis of the Extremities.","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Biocomposites Ltd","sponsor_slug":"biocomposites-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287124","publication_url":"https://clinicaltrials.gov/study/NCT07287124","title":"A Pivotal, Pre-market, Prospective, Interventional, Multi-centre Study to Evaluate Clinical Benefit, Performance, and Safety of the TI1132 Implant in an Adult Population With Sensorineural Hearing Loss","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Cochlear","sponsor_slug":"cochlear","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062471","publication_url":"https://clinicaltrials.gov/study/NCT07062471","title":"Prospective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE Study)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07406633","publication_url":"https://clinicaltrials.gov/study/NCT07406633","title":"A Phase 2, Multicenter, Study Evaluating the Efficacy, Safety, Tolerability, Pharmacokinetics of KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GI Stromal Tumor in 1st Line Setting","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Kumquat Biosciences Inc.","sponsor_slug":"kumquat-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05126888","publication_url":"https://clinicaltrials.gov/study/NCT05126888","title":"A Randomized, Double-Blind, Placebo Controlled, Cross-Over Study to Evaluate the Efficacy, Safety and Tolerability of Daily Oral SCI-110 in Treating Adults With Tourette Syndrome.","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Neurothera Labs Inc.","sponsor_slug":"neurothera-labs-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06226662","publication_url":"https://clinicaltrials.gov/study/NCT06226662","title":"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096726","publication_url":"https://clinicaltrials.gov/study/NCT07096726","title":"Boston Medical Center Ultrasound Decongestion Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201818","publication_url":"https://clinicaltrials.gov/study/NCT07201818","title":"A Randomized Sham-Controlled Trial of Lymphatic Enhancement Technology in the Treatment of Fibromyalgia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494045","publication_url":"https://clinicaltrials.gov/study/NCT07494045","title":"An Open-Label, Randomized, Multiple-Dose, Multi-Center Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of CTAP101 Extended-release Capsules in Pediatric Participants <18 Years of Age With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"OPKO Health, Inc.","sponsor_slug":"opko-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299644","publication_url":"https://clinicaltrials.gov/study/NCT06299644","title":"Endoscopic Sleeve Gastroplasty Technique Comparison for Weight Loss Using the Endomina Plicating Device: A Randomized Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03987386","publication_url":"https://clinicaltrials.gov/study/NCT03987386","title":"Post Operative External Beam Radiotherapy for Prostate Cancer: Randomized Trial Comparing Standard vs. Hypofractionated Radiation Therapy (PORT-HYFX)","has_exemption":false,"start_date":"2019-05-30","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03368729","publication_url":"https://clinicaltrials.gov/study/NCT03368729","title":"A Phase 1b/2 Study of the PARP Inhibitor Niraparib in Combination With Trastuzumab in Patients With Metastatic HER2+ Breast Cancer","has_exemption":false,"start_date":"2019-09-06","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04256317","publication_url":"https://clinicaltrials.gov/study/NCT04256317","title":"A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects With Myeloid Neoplasm or in Combination With Venetoclax in Subjects With AML (AZTOUND Study)","has_exemption":false,"start_date":"2020-05-21","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04604301","publication_url":"https://clinicaltrials.gov/study/NCT04604301","title":"Clinical Evaluation of High Strength Zirconia-Reinforced Lithium Silicate Chairside CAD/CAM Crowns","has_exemption":false,"start_date":"2020-09-24","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04862663","publication_url":"https://clinicaltrials.gov/study/NCT04862663","title":"A Phase Ib/III, Open-label, Randomised Study of Capivasertib Plus CDK4/6 Inhibitors and Fulvestrant Versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)","has_exemption":false,"start_date":"2021-05-10","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268887","publication_url":"https://clinicaltrials.gov/study/NCT05268887","title":"Acute Treatment of Parkinson's Disease With Gamma Frequency Stimulation","has_exemption":false,"start_date":"2022-02-09","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05628779","publication_url":"https://clinicaltrials.gov/study/NCT05628779","title":"Evaluation of the Safety, Efficacy and Cost-effectiveness of Transcatheter Tricuspid Valve Repair in Patients With Severe Tricuspid Regurgitation in the Netherlands.","has_exemption":false,"start_date":"2022-12-12","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"St. Antonius Hospital","sponsor_slug":"st-antonius-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05687266","publication_url":"https://clinicaltrials.gov/study/NCT05687266","title":"A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)","has_exemption":false,"start_date":"2022-12-29","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05723588","publication_url":"https://clinicaltrials.gov/study/NCT05723588","title":"Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD","has_exemption":false,"start_date":"2023-10-31","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06239116","publication_url":"https://clinicaltrials.gov/study/NCT06239116","title":"A Study of RM-718 Weekly Formulation in Healthy Subjects With Obesity and in Patients With Obesity Due to MC4R Impairment","has_exemption":false,"start_date":"2024-03-05","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161532","publication_url":"https://clinicaltrials.gov/study/NCT06161532","title":"A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465953","publication_url":"https://clinicaltrials.gov/study/NCT06465953","title":"A Phase 3, Multicenter, Open Label, Randomized, Non-comparative Two-arm Study of Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Adult Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an Isocitrate Dehydrogenase-1 (IDH1) Mutation (PyramIDH Study)","has_exemption":false,"start_date":"2024-12-03","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06706921","publication_url":"https://clinicaltrials.gov/study/NCT06706921","title":"Usefulness of Tumor Heterogeneity Assessment in Patients With MCRPC Undergoing Radioligand Therapy With 177LU-PSMA-617 Using Serial 18F-DCFPYL, 18F-FDG and 18F-Fluciclovine PET/CT Predicting Clinical Outcome","has_exemption":false,"start_date":"2024-12-15","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"VA Greater Los Angeles Healthcare System","sponsor_slug":"va-greater-los-angeles-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455527","publication_url":"https://clinicaltrials.gov/study/NCT06455527","title":"HRV-Guided tDCS: Integrating A Biomarker For Clinical Utility","has_exemption":false,"start_date":"2025-01-02","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807437","publication_url":"https://clinicaltrials.gov/study/NCT06807437","title":"A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula","has_exemption":false,"start_date":"2025-05-09","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06357676","publication_url":"https://clinicaltrials.gov/study/NCT06357676","title":"Integrated Glofit and Ibrutinib as Novel Immune Therapy Evaluation in Treatment-Naive Mantle Cell Lymphoma (IGNITE MCL): A Phase Ib/II Study of Glofitamab Plus Ibrutinib With Obinutuzumab Pretreatment in MCL Patients ≥ 65 or Ages 18-64 With High-Risk Features","has_exemption":false,"start_date":"2025-05-29","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07017322","publication_url":"https://clinicaltrials.gov/study/NCT07017322","title":"Investigating Non-invasive Cranial Electrotherapy Stimulation for Acute Anxiety in Inpatients With Eating Disorders","has_exemption":false,"start_date":"2025-06-03","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Rogers Behavioral Health","sponsor_slug":"rogers-behavioral-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628128","publication_url":"https://clinicaltrials.gov/study/NCT06628128","title":"An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217912","publication_url":"https://clinicaltrials.gov/study/NCT07217912","title":"Randomized, Double-blind Trial of Daridorexant to Prevent Delirium After Heart Surgery","has_exemption":false,"start_date":"2025-10-14","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226700","publication_url":"https://clinicaltrials.gov/study/NCT07226700","title":"A Randomized, Placebo-controlled, Double-blind Trial of Suzetrigine in Total Hip Arthroplasty","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216872","publication_url":"https://clinicaltrials.gov/study/NCT07216872","title":"A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Brainsway","sponsor_slug":"brainsway","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191860","publication_url":"https://clinicaltrials.gov/study/NCT07191860","title":"A Randomized, Controlled, Multi-Center, Prospective Trial of Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis (OXYGEN-RCT Trial)","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Airiver Medical, Inc.","sponsor_slug":"airiver-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07255248","publication_url":"https://clinicaltrials.gov/study/NCT07255248","title":"Hoffa's Fat Pad Impingement (HFPI): Saline Injection Verus Ultrasound Guided Cortisone Injection: A Randomized Trial in Adolescent Female Athletes","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07059611","publication_url":"https://clinicaltrials.gov/study/NCT07059611","title":"Phase II Study of Neoadjuvant RP2 in Combination With Preoperative Flot for Patients With Stage II or Higher, Non-metastatic Gastroesophageal Adenocarcinoma","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07507409","publication_url":"https://clinicaltrials.gov/study/NCT07507409","title":"Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"Unity Health Toronto","sponsor_slug":"unity-health-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07547319","publication_url":"https://clinicaltrials.gov/study/NCT07547319","title":"Clinical and Neurophysiological Effects of Accelerated rTMS on Cognitive Function: A Prospective Pilot Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"San Francisco Neurology and Sleep Center","sponsor_slug":"san-francisco-neurology-and-sleep-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07554833","publication_url":"https://clinicaltrials.gov/study/NCT07554833","title":"Clinical Effects of Accelerated rTMS Targeting Motor Cortex on Motor and Cognitive Function in Parkinson's Disease: A Prospective Pilot Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"San Francisco Neurology and Sleep Center","sponsor_slug":"san-francisco-neurology-and-sleep-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220226","publication_url":"https://clinicaltrials.gov/study/NCT07220226","title":"Venous Function and the Effect of Venous Compression on Exercise Cardiovascular Function in Patients With Fontan Circulation.","has_exemption":false,"start_date":"2026-05-10","completion_date":"2027-11-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227415","publication_url":"https://clinicaltrials.gov/study/NCT07227415","title":"AN INTERVENTIONAL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY AND IN COMBINATION WITH OTHER ANTICANCER AGENTS IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA","has_exemption":false,"start_date":"2026-03-12","completion_date":"2027-11-02","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05551793","publication_url":"https://clinicaltrials.gov/study/NCT05551793","title":"Dupilumab in the Treatment of Alopecia Areata Patients With an Atopic Background and/or High IgE","has_exemption":false,"start_date":"2023-04-10","completion_date":"2027-11-03","has_results":false,"results_due":false,"sponsor_name":"Emma Guttman","sponsor_slug":"emma-guttman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06750289","publication_url":"https://clinicaltrials.gov/study/NCT06750289","title":"BRISOTE: A Multicentre, Randomised, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist.","has_exemption":false,"start_date":"2025-03-28","completion_date":"2027-11-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784999","publication_url":"https://clinicaltrials.gov/study/NCT06784999","title":"Randomized Prospective Study Comparing Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction","has_exemption":false,"start_date":"2025-01-10","completion_date":"2027-11-04","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07054515","publication_url":"https://clinicaltrials.gov/study/NCT07054515","title":"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-11-04","has_results":false,"results_due":false,"sponsor_name":"Azafaros A.G.","sponsor_slug":"azafaros-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082543","publication_url":"https://clinicaltrials.gov/study/NCT07082543","title":"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-11-04","has_results":false,"results_due":false,"sponsor_name":"Azafaros A.G.","sponsor_slug":"azafaros-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082725","publication_url":"https://clinicaltrials.gov/study/NCT07082725","title":"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-11-04","has_results":false,"results_due":false,"sponsor_name":"Azafaros A.G.","sponsor_slug":"azafaros-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979596","publication_url":"https://clinicaltrials.gov/study/NCT06979596","title":"A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-11-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06508749","publication_url":"https://clinicaltrials.gov/study/NCT06508749","title":"Phase I/II Trial to Evaluate the Impact of Three Broadly Neutralizing Antibodies or Analytic Treatment Interruption on Viral Reservoir, Immune Function, and Maintenance of HIV Suppression in Early Treated Children in Botswana","has_exemption":false,"start_date":"2024-11-11","completion_date":"2027-11-05","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780787","publication_url":"https://clinicaltrials.gov/study/NCT06780787","title":"Phase II Clinical Trial of FOLFOX, Botensilimab, Plus Balstilimab in Patients With Localized Rectal Cancer","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-11-05","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082738","publication_url":"https://clinicaltrials.gov/study/NCT07082738","title":"A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO)","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-11-05","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07099898","publication_url":"https://clinicaltrials.gov/study/NCT07099898","title":"Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-11-05","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07007962","publication_url":"https://clinicaltrials.gov/study/NCT07007962","title":"A Multi-center, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment","has_exemption":false,"start_date":"2025-10-24","completion_date":"2027-11-05","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224035","publication_url":"https://clinicaltrials.gov/study/NCT07224035","title":"Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1","has_exemption":false,"start_date":"2022-10-15","completion_date":"2027-11-06","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224048","publication_url":"https://clinicaltrials.gov/study/NCT07224048","title":"Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-11-06","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07428356","publication_url":"https://clinicaltrials.gov/study/NCT07428356","title":"Histotripsy Ablation for Liver Tumours (HALT): A Multi-centre Prospective Pilot Study on the Safety and Efficacy of Histotripsy in Asian Primary and Secondary Liver Malignancies","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-11-07","has_results":false,"results_due":false,"sponsor_name":"National Cancer Centre, Singapore","sponsor_slug":"national-cancer-centre-singapore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03077841","publication_url":"https://clinicaltrials.gov/study/NCT03077841","title":"Optimizing Preventative Adjuvant Linac-Based Radiation: The OPAL Trial a Phase II/III Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer","has_exemption":false,"start_date":"2017-03-06","completion_date":"2027-11-08","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05064878","publication_url":"https://clinicaltrials.gov/study/NCT05064878","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label Extension","has_exemption":false,"start_date":"2022-03-08","completion_date":"2027-11-08","has_results":false,"results_due":false,"sponsor_name":"Zogenix, Inc.","sponsor_slug":"zogenix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06534983","publication_url":"https://clinicaltrials.gov/study/NCT06534983","title":"A Randomized Phase II, Double-blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-risk Muscle-invasive Urothelial Carcinoma","has_exemption":false,"start_date":"2024-12-09","completion_date":"2027-11-10","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06323980","publication_url":"https://clinicaltrials.gov/study/NCT06323980","title":"Randomized, Prospective, Multi-Center Study of the INHANCE Stemless Total Reverse Shoulder System","has_exemption":false,"start_date":"2025-03-04","completion_date":"2027-11-10","has_results":false,"results_due":false,"sponsor_name":"DePuy Orthopaedics","sponsor_slug":"depuy-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04879121","publication_url":"https://clinicaltrials.gov/study/NCT04879121","title":"A Phase II Basket Study of the Oral TRK Inhibitor Larotrectinib (BAY2757556) in Subjects With NTRK Amplification Positive and Pan-TRK Positive Tumors","has_exemption":false,"start_date":"2021-04-30","completion_date":"2027-11-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05265169","publication_url":"https://clinicaltrials.gov/study/NCT05265169","title":"Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure","has_exemption":false,"start_date":"2023-01-13","completion_date":"2027-11-11","has_results":false,"results_due":false,"sponsor_name":"Society of Interventional Oncology","sponsor_slug":"society-of-interventional-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06908226","publication_url":"https://clinicaltrials.gov/study/NCT06908226","title":"A Phase 3, Open-Label Study to Investigate the Long-Term Safety and Efficacy of LP352 in the Treatment of Seizures in Children and Adults With Developmental and Epileptic Encephalopathy","has_exemption":false,"start_date":"2025-02-12","completion_date":"2027-11-11","has_results":false,"results_due":false,"sponsor_name":"Longboard Pharmaceuticals","sponsor_slug":"longboard-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885034","publication_url":"https://clinicaltrials.gov/study/NCT06885034","title":"A Phase 1b/2, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of GSK5764227 Alone and in Combination in Participants With Previously Treated Advanced Unresectable or Metastatic Gastrointestinal Solid Tumors","has_exemption":false,"start_date":"2025-06-11","completion_date":"2027-11-11","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624670","publication_url":"https://clinicaltrials.gov/study/NCT06624670","title":"A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy","has_exemption":false,"start_date":"2025-02-04","completion_date":"2027-11-12","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06928363","publication_url":"https://clinicaltrials.gov/study/NCT06928363","title":"A First-in-human, Multicenter, Open-label Phase I/II Investigational Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of KY-0301 as Monotherapy in Patients With Advanced Solid Tumors.","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-11-12","has_results":false,"results_due":false,"sponsor_name":"Novatim Immune Therapeutics (Zhejiang) Co., Ltd.","sponsor_slug":"novatim-immune-therapeutics-zhejiang-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276581","publication_url":"https://clinicaltrials.gov/study/NCT07276581","title":"A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-11-12","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05432310","publication_url":"https://clinicaltrials.gov/study/NCT05432310","title":"Efficacy and Safety of Cryopreserved Autologous Mobilized Peripheral Blood CD34+ HSPCs Transduced Ex Vivo With the EFS-ADA Lentiviral Vector in Patients With Severe Combined Immune Deficiency Due To Adenosine Deaminase Deficiency","has_exemption":false,"start_date":"2023-01-04","completion_date":"2027-11-14","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220135","publication_url":"https://clinicaltrials.gov/study/NCT07220135","title":"A Randomized Trial of Neoadjuvant THP vs TCHP for HER2-amplified/Positive Breast Cancer (NeoTHERa)","has_exemption":false,"start_date":"2025-11-14","completion_date":"2027-11-14","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03972657","publication_url":"https://clinicaltrials.gov/study/NCT03972657","title":"A Phase 1/2 Study of REGN5678 (Anti-PSMAxCD28) With or Without Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-Resistant Prostate Cancer and Other Tumors Associated With PSMA Expression","has_exemption":false,"start_date":"2019-08-12","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05075980","publication_url":"https://clinicaltrials.gov/study/NCT05075980","title":"HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers","has_exemption":false,"start_date":"2022-02-16","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06007690","publication_url":"https://clinicaltrials.gov/study/NCT06007690","title":"A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Aura Biosciences","sponsor_slug":"aura-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159166","publication_url":"https://clinicaltrials.gov/study/NCT06159166","title":"A Phase 1/2a Open-label, Multicenter Dose Finding Study to Evaluate the Safety and Anti-tumor Activity of Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).","has_exemption":false,"start_date":"2024-02-12","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603246","publication_url":"https://clinicaltrials.gov/study/NCT06603246","title":"A Phase Ic, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Inhaled GDC-6988 in Patients With Muco-obstructive Disease","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06952478","publication_url":"https://clinicaltrials.gov/study/NCT06952478","title":"A Double-Blind, Randomized, Active-Controlled, Parallel-group, Phase 1/3 Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Celltrion","sponsor_slug":"celltrion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07236437","publication_url":"https://clinicaltrials.gov/study/NCT07236437","title":"Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care","has_exemption":false,"start_date":"2025-11-15","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Scott A. Irwin, MD, PhD","sponsor_slug":"scott-a-irwin-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482176","publication_url":"https://clinicaltrials.gov/study/NCT07482176","title":"A Multi-center, Randomized, Double-masked, Active-comparator-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)","has_exemption":false,"start_date":"2026-03-16","completion_date":"2027-11-15","has_results":false,"results_due":false,"sponsor_name":"Adverum Biotechnologies, Inc.","sponsor_slug":"adverum-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04108156","publication_url":"https://clinicaltrials.gov/study/NCT04108156","title":"A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)","has_exemption":true,"start_date":"2019-09-30","completion_date":"2027-11-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04975997","publication_url":"https://clinicaltrials.gov/study/NCT04975997","title":"A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects With Relapsed or Refractory Multiple Myeloma (RRMM)","has_exemption":false,"start_date":"2022-06-23","completion_date":"2027-11-16","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953583","publication_url":"https://clinicaltrials.gov/study/NCT06953583","title":"A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled Study (Part 1) and Open-Label Extension (Part 2) to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omaveloxolone (BIIB141) in Participants With Friedreich's Ataxia Aged 2 to < 16 Years","has_exemption":false,"start_date":"2025-06-09","completion_date":"2027-11-16","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06991257","publication_url":"https://clinicaltrials.gov/study/NCT06991257","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN ORAL BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE INHIBITOR, PF-07328948, IN ADULTS WITH HEART FAILURE (BRANCH-HF)","has_exemption":false,"start_date":"2025-06-19","completion_date":"2027-11-16","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04068649","publication_url":"https://clinicaltrials.gov/study/NCT04068649","title":"A Phase 2 Randomized Study With a Non-randomized Cohort : Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients With Metastatic Disease (ASTEROID)","has_exemption":false,"start_date":"2019-11-18","completion_date":"2027-11-18","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03976843","publication_url":"https://clinicaltrials.gov/study/NCT03976843","title":"A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer","has_exemption":false,"start_date":"2019-12-04","completion_date":"2027-11-19","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06097728","publication_url":"https://clinicaltrials.gov/study/NCT06097728","title":"A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma (eVOLVE-Meso)","has_exemption":false,"start_date":"2023-11-09","completion_date":"2027-11-19","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225946","publication_url":"https://clinicaltrials.gov/study/NCT07225946","title":"A Phase 3 Randomized, Open-label Study of Pasritamig (JNJ-78278343), a T-cell-redirecting Agent Targeting Human Kallikrein 2, With Docetaxel Versus Docetaxel for Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-11-19","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540364","publication_url":"https://clinicaltrials.gov/study/NCT07540364","title":"A Phase 3, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Samelisant Compared to Placebo in Patients With Narcolepsy With or Without Cataplexy","has_exemption":false,"start_date":"2026-06-19","completion_date":"2027-11-19","has_results":false,"results_due":false,"sponsor_name":"Suven Life Sciences Limited","sponsor_slug":"suven-life-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05497804","publication_url":"https://clinicaltrials.gov/study/NCT05497804","title":"REsponse Adapted Combination Therapy Approaches for High-Risk Multiple Myeloma (REACH)","has_exemption":false,"start_date":"2022-09-22","completion_date":"2027-11-20","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06567015","publication_url":"https://clinicaltrials.gov/study/NCT06567015","title":"Phase I/II First-In-Human Open-label Trial to Assess Safety and Efficacy of STX-241 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Resistant to EGFR Tyrosine Kinase Inhibitors (TKIs).","has_exemption":false,"start_date":"2024-09-17","completion_date":"2027-11-20","has_results":false,"results_due":false,"sponsor_name":"Pierre Fabre Medicament","sponsor_slug":"pierre-fabre-medicament","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05357092","publication_url":"https://clinicaltrials.gov/study/NCT05357092","title":"Evaluation of Presurgical Orthopedics in Patients With Cleft Lip and/or Palate, a Randomized Controlled Clinial Trial.","has_exemption":false,"start_date":"2025-11-21","completion_date":"2027-11-21","has_results":false,"results_due":false,"sponsor_name":"Universidad Complutense de Madrid","sponsor_slug":"universidad-complutense-de-madrid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473700","publication_url":"https://clinicaltrials.gov/study/NCT07473700","title":"An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease","has_exemption":false,"start_date":"2026-03-30","completion_date":"2027-11-21","has_results":false,"results_due":false,"sponsor_name":"Tectonic Operating Company, Inc.","sponsor_slug":"tectonic-operating-company-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05092347","publication_url":"https://clinicaltrials.gov/study/NCT05092347","title":"A Dose Escalation and Proof-of-Concept Study of Vonsetamig (BCMA × CD3 Bispecific Antibody) for Desensitization of Chronic Kidney Disease Patients in Need of Kidney Transplantation Who Are Highly Sensitized to Human Leukocyte Antigen","has_exemption":false,"start_date":"2022-08-02","completion_date":"2027-11-22","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308847","publication_url":"https://clinicaltrials.gov/study/NCT07308847","title":"Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Prospective, Single Arm, Unblinded Pre-market Clinical Study to Evaluate the Safety and Effectiveness of the Sphere-360 Catheter and Affera Mapping and Ablation System for Treating Paroxysmal Atrial Fibrillation (PAF)","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-11-22","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288177","publication_url":"https://clinicaltrials.gov/study/NCT07288177","title":"A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-01-30","completion_date":"2027-11-22","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293403","publication_url":"https://clinicaltrials.gov/study/NCT07293403","title":"A Phase II Study of Duvelisib Maintenance After First-Line Therapy for Peripheral T-Cell Lymphoma","has_exemption":false,"start_date":"2026-06-07","completion_date":"2027-11-23","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04521231","publication_url":"https://clinicaltrials.gov/study/NCT04521231","title":"A Phase 1/2 Open-label Study to Investigate the Safety, Efficacy, and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL","has_exemption":false,"start_date":"2021-01-04","completion_date":"2027-11-24","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852717","publication_url":"https://clinicaltrials.gov/study/NCT05852717","title":"A Phase II Trial Evaluating Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma","has_exemption":false,"start_date":"2023-10-31","completion_date":"2027-11-24","has_results":false,"results_due":false,"sponsor_name":"Dipenkumar Modi","sponsor_slug":"dipenkumar-modi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281118","publication_url":"https://clinicaltrials.gov/study/NCT07281118","title":"Intercostal Cryoanalgesia in Double Lung Transplant Recipients","has_exemption":false,"start_date":"2025-12-16","completion_date":"2027-11-24","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07254806","publication_url":"https://clinicaltrials.gov/study/NCT07254806","title":"A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-11-24","has_results":false,"results_due":false,"sponsor_name":"DiscGenics, Inc.","sponsor_slug":"discgenics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06980038","publication_url":"https://clinicaltrials.gov/study/NCT06980038","title":"A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery","has_exemption":false,"start_date":"2026-08-21","completion_date":"2027-11-24","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698796","publication_url":"https://clinicaltrials.gov/study/NCT06698796","title":"A PHASE 3, MULTI-CENTER, OPEN-LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF DAZUKIBART IN PARTICIPANTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH DERMATOMYOSITIS OR POLYMYOSITIS)","has_exemption":false,"start_date":"2025-01-22","completion_date":"2027-11-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129343","publication_url":"https://clinicaltrials.gov/study/NCT07129343","title":"A Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in the Treatment of Bleeding Episodes in Chinese Subjects Diagnosed With Von Willebrand Disease","has_exemption":false,"start_date":"2025-10-13","completion_date":"2027-11-25","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06917911","publication_url":"https://clinicaltrials.gov/study/NCT06917911","title":"Phase II Study of Cytarabine + Daunorubicin (7 + 3) + Gemtuzumab Ozogamicin vs. Cytarabine + Daunorubicin (7 + 3) + Venetoclax for the Treatment of Newly Diagnosed Core Binding Factor Acute Myeloid Leukemia (CBF-AML) in Younger Adults: A MyeloMATCH Substudy","has_exemption":false,"start_date":"2026-06-18","completion_date":"2027-11-25","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03331198","publication_url":"https://clinicaltrials.gov/study/NCT03331198","title":"An Open-Label, Phase 1/2 Study of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)","has_exemption":false,"start_date":"2017-11-27","completion_date":"2027-11-26","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, a Subsidiary of Celgene","sponsor_slug":"juno-therapeutics-a-subsidiary-of-celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06079671","publication_url":"https://clinicaltrials.gov/study/NCT06079671","title":"A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-centre, Global Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer Who Have Not Progressed Following Platinum-based, Concurrent Chemoradiation Therapy (eVOLVE-Cervical)","has_exemption":false,"start_date":"2023-09-22","completion_date":"2027-11-26","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06808984","publication_url":"https://clinicaltrials.gov/study/NCT06808984","title":"A Phase 2, Randomized, Double-blind, Three-Arm, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Agitation in Participants With Alzheimer's Disease (BALANCE-AAD-1)","has_exemption":false,"start_date":"2025-06-09","completion_date":"2027-11-26","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797518","publication_url":"https://clinicaltrials.gov/study/NCT06797518","title":"A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care","has_exemption":false,"start_date":"2025-02-21","completion_date":"2027-11-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04774393","publication_url":"https://clinicaltrials.gov/study/NCT04774393","title":"Phase 1b/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib","has_exemption":false,"start_date":"2021-05-24","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06084338","publication_url":"https://clinicaltrials.gov/study/NCT06084338","title":"Phase II Trial of Targeted Radiation With no Castration for Mcrpc","has_exemption":false,"start_date":"2023-12-14","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06541704","publication_url":"https://clinicaltrials.gov/study/NCT06541704","title":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration","has_exemption":false,"start_date":"2024-10-30","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089875","publication_url":"https://clinicaltrials.gov/study/NCT07089875","title":"A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout","has_exemption":false,"start_date":"2025-08-01","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"Crystalys Therapeutics","sponsor_slug":"crystalys-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07404852","publication_url":"https://clinicaltrials.gov/study/NCT07404852","title":"Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct 2","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357766","publication_url":"https://clinicaltrials.gov/study/NCT07357766","title":"A Placebo-controlled Comparability Study to Compare Two Presentations of CagriSema in Participants With Overweight or Obesity","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-11-29","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02352883","publication_url":"https://clinicaltrials.gov/study/NCT02352883","title":"Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)","has_exemption":false,"start_date":"2015-03-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02659293","publication_url":"https://clinicaltrials.gov/study/NCT02659293","title":"Phase 3 Randomized Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma","has_exemption":false,"start_date":"2016-04-26","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03036319","publication_url":"https://clinicaltrials.gov/study/NCT03036319","title":"Patient-Centered NeuroRehabilitation","has_exemption":false,"start_date":"2016-06-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02974647","publication_url":"https://clinicaltrials.gov/study/NCT02974647","title":"Phase II Multicenter Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma","has_exemption":false,"start_date":"2016-11-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03263572","publication_url":"https://clinicaltrials.gov/study/NCT03263572","title":"Phase II Study of the Combination of Blinatumomab and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)","has_exemption":false,"start_date":"2017-11-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03554083","publication_url":"https://clinicaltrials.gov/study/NCT03554083","title":"Neoadjuvant Therapy for Patients With High Risk Stage III Melanoma: A Pilot Clinical Trial","has_exemption":false,"start_date":"2018-10-05","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03672539","publication_url":"https://clinicaltrials.gov/study/NCT03672539","title":"A Pilot Study of Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination With Gemtuzumab Ozogamicin (GO) in Relapsed Refractory Patients With Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)","has_exemption":false,"start_date":"2018-11-07","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04151940","publication_url":"https://clinicaltrials.gov/study/NCT04151940","title":"An Interventional Study of PET/CT Changes During Chemoimmunotherapy and Radiation Therapy for Patients With Metastatic NSCLC (PET Bright)","has_exemption":false,"start_date":"2019-09-26","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04170283","publication_url":"https://clinicaltrials.gov/study/NCT04170283","title":"An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Patients With B-cell Malignancies","has_exemption":false,"start_date":"2020-01-16","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"BeiGene","sponsor_slug":"beigene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04219254","publication_url":"https://clinicaltrials.gov/study/NCT04219254","title":"A Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2020-06-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04329728","publication_url":"https://clinicaltrials.gov/study/NCT04329728","title":"An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)","has_exemption":false,"start_date":"2020-11-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"AVM Biotechnology Inc","sponsor_slug":"avm-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04759911","publication_url":"https://clinicaltrials.gov/study/NCT04759911","title":"Neoadjuvant Treatment With Selpercatinib in RET-Altered Thyroid Cancers","has_exemption":false,"start_date":"2021-02-26","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05026866","publication_url":"https://clinicaltrials.gov/study/NCT05026866","title":"A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease","has_exemption":false,"start_date":"2021-08-27","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05130801","publication_url":"https://clinicaltrials.gov/study/NCT05130801","title":"Phase I/IIa Study of Pre-operative Multiparametric MRI and pHLIP® ICG Intra-operative Fluorescence Imaging of Primary Breast Cancer","has_exemption":false,"start_date":"2021-11-19","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309668","publication_url":"https://clinicaltrials.gov/study/NCT05309668","title":"A Phase I/II, Single-Arm, Open Label Study to Evaluate the Pharmacokinetics, Safety/Tolerability and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With Neurofibromatosis Type 1 (NF1) Related Symptomatic, Inoperable Plexiform Neurofibromas (PN) (SPRINKLE)","has_exemption":false,"start_date":"2022-01-21","completion_date":"2027-11-30","has_results":true,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05354141","publication_url":"https://clinicaltrials.gov/study/NCT05354141","title":"Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles for Hospitalized Patients With Moderate-to-Severe ARDS: A Phase III Clinical Trial","has_exemption":false,"start_date":"2022-07-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Direct Biologics, LLC","sponsor_slug":"direct-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05194111","publication_url":"https://clinicaltrials.gov/study/NCT05194111","title":"Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (Treat HF)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05603572","publication_url":"https://clinicaltrials.gov/study/NCT05603572","title":"A Multi-center, Open-label, Phase 1/2a Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of KAT-101 in Subjects With HCC","has_exemption":false,"start_date":"2022-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Primocure Pharma","sponsor_slug":"primocure-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05607108","publication_url":"https://clinicaltrials.gov/study/NCT05607108","title":"Phase 2 Trial of ZEN003694 in Squamous Cell Lung Cancer Patients Harboring NSD3 Amplification","has_exemption":false,"start_date":"2022-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05702229","publication_url":"https://clinicaltrials.gov/study/NCT05702229","title":"An Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2023-01-16","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05642780","publication_url":"https://clinicaltrials.gov/study/NCT05642780","title":"A Multicenter, Open-label, Phase 2, Basket Study to Evaluate the Efficacy and Safety of SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors","has_exemption":false,"start_date":"2023-01-17","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Klus Pharma Inc.","sponsor_slug":"klus-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05275972","publication_url":"https://clinicaltrials.gov/study/NCT05275972","title":"Descemet Endothelial Thickness Comparison Trials (DETECT I & II)","has_exemption":false,"start_date":"2023-01-23","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757141","publication_url":"https://clinicaltrials.gov/study/NCT05757141","title":"A Phase 1b/2 Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy Following Fosigotifator Administration in Adult and Pediatric Subjects With Vanishing White Matter Disease","has_exemption":false,"start_date":"2023-03-13","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Calico Life Sciences LLC","sponsor_slug":"calico-life-sciences-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04858256","publication_url":"https://clinicaltrials.gov/study/NCT04858256","title":"Phase 2, Open Label, Multicenter Study of Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms","has_exemption":false,"start_date":"2023-03-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082453","publication_url":"https://clinicaltrials.gov/study/NCT06082453","title":"Modernizing Perinatal Syphilis Testing","has_exemption":false,"start_date":"2023-05-02","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05735717","publication_url":"https://clinicaltrials.gov/study/NCT05735717","title":"Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies","has_exemption":false,"start_date":"2023-05-11","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05889273","publication_url":"https://clinicaltrials.gov/study/NCT05889273","title":"An Open-label Extension Study to Investigate Safety and Tolerability of ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD).","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"MapLight Therapeutics","sponsor_slug":"maplight-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05748834","publication_url":"https://clinicaltrials.gov/study/NCT05748834","title":"Phase 2 Single Arm Trial With a Safety Lead-in of Tucatinib in Combination With Doxil for the Treatment of HER2+ Metastatic Breast Cancer","has_exemption":false,"start_date":"2023-07-24","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"SCRI Development Innovations, LLC","sponsor_slug":"scri-development-innovations-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06043440","publication_url":"https://clinicaltrials.gov/study/NCT06043440","title":"Randomized Control Trial of Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea","has_exemption":false,"start_date":"2023-10-24","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05943535","publication_url":"https://clinicaltrials.gov/study/NCT05943535","title":"A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)","has_exemption":false,"start_date":"2023-10-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"United Therapeutics","sponsor_slug":"united-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849038","publication_url":"https://clinicaltrials.gov/study/NCT05849038","title":"The Role of Inflammation in Central Nervous System (CNS) Mechanisms of Anhedonia and Psychomotor Slowing in Depressed People With HIV","has_exemption":false,"start_date":"2023-12-11","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06090227","publication_url":"https://clinicaltrials.gov/study/NCT06090227","title":"AMPK-activation by Metformin in FSGS: AMP-FSGS","has_exemption":false,"start_date":"2023-12-14","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06119581","publication_url":"https://clinicaltrials.gov/study/NCT06119581","title":"SUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression ≥50% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression","has_exemption":false,"start_date":"2023-12-21","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06110793","publication_url":"https://clinicaltrials.gov/study/NCT06110793","title":"A Phase Ib/II Trial of Lenvatinib Plus Pembrolizumab Plus Fulvestrant in ER-positive/ HER2- Negative Metastatic Breast Cancer","has_exemption":false,"start_date":"2023-12-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05731856","publication_url":"https://clinicaltrials.gov/study/NCT05731856","title":"Impact of Heart Rate Variability Modulation on Stress and Recovery Among Physicians","has_exemption":false,"start_date":"2024-01-15","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Michelle Thompson","sponsor_slug":"michelle-thompson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06008197","publication_url":"https://clinicaltrials.gov/study/NCT06008197","title":"Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)","has_exemption":false,"start_date":"2024-01-17","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Colorado Prevention Center","sponsor_slug":"colorado-prevention-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06123338","publication_url":"https://clinicaltrials.gov/study/NCT06123338","title":"A Single-Arm, Multicenter Phase 2 Study of Neoadjuvant Pembrolizumab With Trastuzumab and Chemotherapy in Resectable HER2+ Esophagogastric Tumors","has_exemption":false,"start_date":"2024-02-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305559","publication_url":"https://clinicaltrials.gov/study/NCT06305559","title":"A Placebo-controlled, Double-blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib/Ezetimibe Fixed Dose Combination Daily on Coronary Plaque Characteristics in Participants With Atherosclerotic Cardiovascular Disease on Coronary CT Angiography (REMBRANDT Trial)","has_exemption":false,"start_date":"2024-05-16","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"NewAmsterdam Pharma","sponsor_slug":"newamsterdam-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837455","publication_url":"https://clinicaltrials.gov/study/NCT05837455","title":"NeoTAILOR: A Phase II Biomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer","has_exemption":false,"start_date":"2024-05-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569823","publication_url":"https://clinicaltrials.gov/study/NCT06569823","title":"A Phase 1/2 Randomized, Observer-Blinded, Active-Controlled, Dose, Escalation Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Participants 50 Years of Age and Over","has_exemption":false,"start_date":"2024-06-17","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Dynavax Technologies Corporation","sponsor_slug":"dynavax-technologies-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06488105","publication_url":"https://clinicaltrials.gov/study/NCT06488105","title":"Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) Trial","has_exemption":false,"start_date":"2024-08-05","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05610735","publication_url":"https://clinicaltrials.gov/study/NCT05610735","title":"Combination Therapy With Liposomal Doxorubicin and Withaferin A (Ashwagandha, ASWD) in Recurrent Ovarian Cancer","has_exemption":false,"start_date":"2024-09-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Sham Sunder Kakar","sponsor_slug":"sham-sunder-kakar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526624","publication_url":"https://clinicaltrials.gov/study/NCT06526624","title":"ARTEMIS-009: A Phase 3, Randomized, Controlled, Multi-center, Open-label Study of HS-20093 Versus Active Surveillance As Consolidation Therapy After Chemoradiotherapy in Subjects With Limited-Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Hansoh BioMedical R&D Company","sponsor_slug":"hansoh-biomedical-rd-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561048","publication_url":"https://clinicaltrials.gov/study/NCT06561048","title":"A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma","has_exemption":false,"start_date":"2024-10-02","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Corvus Pharmaceuticals, Inc.","sponsor_slug":"corvus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06626139","publication_url":"https://clinicaltrials.gov/study/NCT06626139","title":"2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers","has_exemption":false,"start_date":"2024-10-20","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Robin Carhart-Harris, PhD, MA","sponsor_slug":"robin-carhart-harris-phd-ma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06413706","publication_url":"https://clinicaltrials.gov/study/NCT06413706","title":"A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Temozolomide Compared to Temozolomide Monotherapy in Children and Young Adults With Newly Diagnosed High-Grade Glioma Following Radiotherapy","has_exemption":false,"start_date":"2024-10-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005311","publication_url":"https://clinicaltrials.gov/study/NCT06005311","title":"A Randomized Double-blind Controlled Study of the Cumulative Live Birth Rate of IVF Following Sperm Preparation by Microfluidic Chip Method Versus Density-gradient Centrifugation Method","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Professor Ernest Hung-Yu Ng","sponsor_slug":"professor-ernest-hung-yu-ng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023472","publication_url":"https://clinicaltrials.gov/study/NCT06023472","title":"A Randomized Comparison of Microfluidic Chip vs Density Gradient Centrifugation on the Euploidy Rate of Pre-implantation Genetic Testing","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Professor Ernest Hung-Yu Ng","sponsor_slug":"professor-ernest-hung-yu-ng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06650202","publication_url":"https://clinicaltrials.gov/study/NCT06650202","title":"Improving Balance After Spinal Cord Injury Using a Robotic Upright Stand Trainer and Spinal Cord Epidural Stimulation","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679829","publication_url":"https://clinicaltrials.gov/study/NCT06679829","title":"Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesrus BSA Based Melphalan in Patients With Multiple Myeloma Over Age 60 Undergoing Autologous Stem Cell Transplantation","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06605118","publication_url":"https://clinicaltrials.gov/study/NCT06605118","title":"Azithromycin Prophylaxis for Prelabor Cesarean Delivery Trial","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"The George Washington University Biostatistics Center","sponsor_slug":"the-george-washington-university-biostatistics-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660368","publication_url":"https://clinicaltrials.gov/study/NCT06660368","title":"A Prospective, Multicenter, Randomized, Open-Label, Phase II Study of Salvage BCL2i Plus CLAG-M in Relapsed or Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-11-26","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588634","publication_url":"https://clinicaltrials.gov/study/NCT06588634","title":"The PERSEVERE Study","has_exemption":false,"start_date":"2024-12-16","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Inari Medical","sponsor_slug":"inari-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06011551","publication_url":"https://clinicaltrials.gov/study/NCT06011551","title":"HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs","has_exemption":false,"start_date":"2025-01-13","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"ReGelTec, Inc.","sponsor_slug":"regeltec-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641271","publication_url":"https://clinicaltrials.gov/study/NCT06641271","title":"Vagus Nerve Stimulation to Promote Remyelination in Multiple Sclerosis","has_exemption":false,"start_date":"2025-01-21","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06478212","publication_url":"https://clinicaltrials.gov/study/NCT06478212","title":"A Phase 1b/2, Multicenter Study of Vorasidenib in Combination With Temozolomide (TMZ) in Participants With IDH1- or IDH2-mutant Glioma","has_exemption":false,"start_date":"2025-01-22","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533163","publication_url":"https://clinicaltrials.gov/study/NCT06533163","title":"Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial","has_exemption":false,"start_date":"2025-02-17","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"BioTex, Inc.","sponsor_slug":"biotex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712823","publication_url":"https://clinicaltrials.gov/study/NCT06712823","title":"An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894","has_exemption":false,"start_date":"2025-02-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05670951","publication_url":"https://clinicaltrials.gov/study/NCT05670951","title":"A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants","has_exemption":false,"start_date":"2025-02-27","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Elgan Pharma Ltd.","sponsor_slug":"elgan-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06772623","publication_url":"https://clinicaltrials.gov/study/NCT06772623","title":"An Open-label Multi-Cohort Phase 1b/2 Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease and No Actionable Genomic Alterations","has_exemption":false,"start_date":"2025-03-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864026","publication_url":"https://clinicaltrials.gov/study/NCT06864026","title":"A Phase 4, Prospective, Open-Label, Single-Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice.","has_exemption":false,"start_date":"2025-03-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809140","publication_url":"https://clinicaltrials.gov/study/NCT06809140","title":"Phase 2 Trial of Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Urothelial Cancer of the Bladder","has_exemption":false,"start_date":"2025-04-07","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Matthew Galsky","sponsor_slug":"matthew-galsky","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06920043","publication_url":"https://clinicaltrials.gov/study/NCT06920043","title":"A Phase 2, Randomized, Double-blinded, Placebo-controlled Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)","has_exemption":false,"start_date":"2025-04-09","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Boston Pharmaceuticals","sponsor_slug":"boston-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953869","publication_url":"https://clinicaltrials.gov/study/NCT06953869","title":"A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia","has_exemption":false,"start_date":"2025-04-21","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961968","publication_url":"https://clinicaltrials.gov/study/NCT06961968","title":"A Multicenter, Double-Blind, Randomized Withdrawal Study in Patients With Schizophrenia Receiving Either Iloperidone Long-Acting Injection (LAI) or Placebo Injection","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973564","publication_url":"https://clinicaltrials.gov/study/NCT06973564","title":"A Phase 1/2a, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of JAB-23E73 in Adult Patients With Advanced Solid Tumors With KRAS Alteration","has_exemption":false,"start_date":"2025-05-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Jacobio Pharmaceuticals Co., Ltd.","sponsor_slug":"jacobio-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023731","publication_url":"https://clinicaltrials.gov/study/NCT07023731","title":"A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors","has_exemption":false,"start_date":"2025-05-29","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Arvinas Inc","sponsor_slug":"arvinas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891443","publication_url":"https://clinicaltrials.gov/study/NCT06891443","title":"A Double-Masked, Randomized, Placebo-Controlled, Paired-Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Laboratoires Thea","sponsor_slug":"laboratoires-thea","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06303869","publication_url":"https://clinicaltrials.gov/study/NCT06303869","title":"Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke","has_exemption":false,"start_date":"2025-06-20","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Jorge Gonzalez-Martinez","sponsor_slug":"jorge-gonzalez-martinez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145763","publication_url":"https://clinicaltrials.gov/study/NCT06145763","title":"Digital Smoking Cessation Intervention for Nationally-Recruited American Indians and Alaska Natives: A Full-Scale Randomized Controlled Trial (IndigeQuit)","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06983028","publication_url":"https://clinicaltrials.gov/study/NCT06983028","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER)","has_exemption":false,"start_date":"2025-07-07","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Vera Therapeutics, Inc.","sponsor_slug":"vera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105098","publication_url":"https://clinicaltrials.gov/study/NCT07105098","title":"A Global, Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07101614","publication_url":"https://clinicaltrials.gov/study/NCT07101614","title":"An Open-label, Randomized, Multi-center, Multi-cohort Clinical Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Shengjing Hospital","sponsor_slug":"shengjing-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06728423","publication_url":"https://clinicaltrials.gov/study/NCT06728423","title":"SmartGuard vs Temp Target in Patients With Type 1 Diabetes Users AHCL in Anaerobic Exercise","has_exemption":false,"start_date":"2025-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitario San Ignacio","sponsor_slug":"hospital-universitario-san-ignacio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07128342","publication_url":"https://clinicaltrials.gov/study/NCT07128342","title":"Use of Continuous Glucose Monitoring in Veterans With Uncontrolled Diabetes Managed Without Insulin Therapy","has_exemption":false,"start_date":"2025-11-01","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Milwaukee VA Medical Center","sponsor_slug":"milwaukee-va-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221760","publication_url":"https://clinicaltrials.gov/study/NCT07221760","title":"An Open-label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Dentatorubral-pallidoluysian Atrophy (DRPLA) Due to ATN1 Mutation","has_exemption":false,"start_date":"2025-11-06","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07190807","publication_url":"https://clinicaltrials.gov/study/NCT07190807","title":"Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control (MOSAIC Study)","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227792","publication_url":"https://clinicaltrials.gov/study/NCT07227792","title":"Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer","has_exemption":false,"start_date":"2025-11-23","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Yvonne Mowery","sponsor_slug":"yvonne-mowery","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286175","publication_url":"https://clinicaltrials.gov/study/NCT07286175","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142291","publication_url":"https://clinicaltrials.gov/study/NCT07142291","title":"A Phase IIB Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Study to Evaluate the Effects of PHENOGENE-1A (Cromolyn) as an Adjuvant Treatment in Subjects With Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-11-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"PhenoNet, Inc.","sponsor_slug":"phenonet-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187531","publication_url":"https://clinicaltrials.gov/study/NCT07187531","title":"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Dose Finding Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients With Stage 3 New Onset of Type 1 Diabetes (NOT1D)","has_exemption":false,"start_date":"2025-11-25","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"SAb Biotherapeutics, Inc.","sponsor_slug":"sab-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07203092","publication_url":"https://clinicaltrials.gov/study/NCT07203092","title":"Effects of Transcranial Photobiomodulation on Cognition and Brain Metabolism in Adults With ADHD","has_exemption":false,"start_date":"2025-11-30","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216443","publication_url":"https://clinicaltrials.gov/study/NCT07216443","title":"A Phase 2 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome","has_exemption":false,"start_date":"2025-12-09","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Orca Biosystems, Inc.","sponsor_slug":"orca-biosystems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062588","publication_url":"https://clinicaltrials.gov/study/NCT07062588","title":"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)","has_exemption":false,"start_date":"2025-12-12","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Angitia Incorporated Limited","sponsor_slug":"angitia-incorporated-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07245641","publication_url":"https://clinicaltrials.gov/study/NCT07245641","title":"Targeted Accelerated TMS for Post-Traumatic Stress Disorder","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07078383","publication_url":"https://clinicaltrials.gov/study/NCT07078383","title":"Evaluation of the Rapidlink Device for Use in the Repair or Replacement of the Supra-Aortic Vessels During an Open Surgical Procedure of the Thoracic Aorta","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-11-30","has_results":false,"results_due":false,"sponsor_name":"Vascutek Ltd.","sponsor_slug":"vascutek-ltd","status":"ongoing","is_pact":false,"days_late":null}]}